Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation collaboration and integrity. Rezolute’s lead investigational therapy RZ358 (ersodetug) is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). Position Description Overview A key member of Rezolute’s Technical Operations Leadership team the Vice President Global Manufacturing has the mandate to provide the vision leadership strategy and management skills to build lead and oversee Rezolute’s fully externalized global biologics manufacturing network from cell … Sign In to View